×
PROCEPT BioRobotics Receivables 2021-2025 | PRCT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
PROCEPT BioRobotics receivables from 2021 to 2025. Receivables can be defined as the total amount of collectibles for a company
View More
PROCEPT BioRobotics Receivables 2021-2025 | PRCT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
PROCEPT BioRobotics receivables from 2021 to 2025. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$179.3B
Intuitive Surgical (ISRG)
$175.2B
Alcon (ALC)
$45.3B
Edwards Lifesciences (EW)
$44.5B
IDEXX Laboratories (IDXX)
$44.2B
IQVIA Holdings (IQV)
$34.1B
DexCom (DXCM)
$34B
Mettler-Toledo (MTD)
$26.2B
STERIS (STE)
$22.4B
Waters (WAT)
$17.8B
SONOVA HOLDING (SONVY)
$17.5B
Hologic (HOLX)
$14.7B
Sysmex ADR (SSMXY)
$10.9B
Penumbra (PEN)
$8.9B
Masimo (MASI)
$8.7B
Globus Medical (GMED)
$7.2B
Glaukos (GKOS)
$5.4B
Teleflex (TFX)
$5.1B
Integer Holdings (ITGR)
$3.7B
TransMedics (TMDX)
$3.6B
LivaNova (LIVN)
$2.4B
Nihon Kohden (NHNKY)
$2.1B
Elekta AB (EKTAY)
$2B
Veracyte (VCYT)
$1.8B
Alphatec Holdings (ATEC)
$1.6B
Artivion (AORT)
$1.3B
OPKO Health (OPK)
$1.1B
Paragon 28 (FNA)
$1.1B
Tandem Diabetes Care (TNDM)
$1B
Pulse Biosciences (PLSE)
$1B